Patents Assigned to GENIMMUNE
  • PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUS
    Publication number: 20100099613
    Abstract: The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 22, 2010
    Applicants: GENIMMUNE, PHARMEXA INC.
    Inventors: Marie-Ange Buyse, Geert Maertens, Erik Depla, Ignace Lasters, Johan Desmet, Denise Baker, Robert W. Chesnut, Mark Newman, Alessandra Sette, John Sidney, Scott Southwood